Publications by the researcher in collaboration with Peter J. Parker (10)

2021

  1. Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation Cohorts

    Gastroenterology, Vol. 161, Núm. 4, pp. 1179-1193

  2. Quantification of biomarker functionality predicts patient outcomes

    British Journal of Cancer

2020

  1. High PD-1/PD-L1 checkpoint interaction infers tumor selection and therapeutic sensitivity to anti-PD-1/PD-L1 treatment

    Cancer Research, Vol. 80, Núm. 19, pp. 4244-4257

2017

  1. Time resolved amplified FRET identifies protein kinase B activation state as a marker for poor prognosis in clear cell renal cell carcinoma

    BBA Clinical, Vol. 8, pp. 97-102

  2. Uncoupling TORC2 from AGC kinases inhibits tumour growth

    Oncotarget, Vol. 8, Núm. 49, pp. 84685-84696

2016

  1. Erratum to: HER2 Phosphorylation Is Maintained by a PKB Negative Feedback Loop in Response to Anti-HER2 Herceptin in Breast Cancer (PLoS Biol)

    PLoS Biology

2015

  1. Functional proteomic biomarkers in cancer

    Annals of the New York Academy of Sciences, Vol. 1346, Núm. 1, pp. 1-6

2014

  1. Acute regulation of PDK1 by a complex interplay of molecular switches

    Biochemical Society Transactions, Vol. 42, Núm. 5, pp. 1435-1440

  2. Functional implications of assigned, assumed and assembled PKC structures

    Biochemical Society Transactions, Vol. 42, Núm. 1, pp. 35-41

  3. High-throughput time-resolved FRET reveals Akt/PKB activation as a poor prognostic marker in breast cancer

    Cancer Research, Vol. 74, Núm. 18, pp. 4983-4995